| Sector |
Chemicals
|
Compare with Sector peers |
| Industry |
Pesticides & Agrochemicals
|
Compare with Industry peers |
| Website | http://www.kilpest.com | |
| Market Cap | 530.79 Cr. | |
| Enterprise Value(EV) | 472.31 Cr. | 2023-09 |
| Financial Indicators | ||
|---|---|---|
| Earnings per share (EPS) | 36.48 | Trailing Twelve Months Ending 2023-12 |
| Price-Earning Ratio (PE) | 19.38 | Trailing Twelve Months Ending 2023-12 |
| Industry PE | 50.49 | Trailing Twelve Months Ending 2023-12 |
| Book Value / Share | 287.44 | Trailing Twelve Months Ending 2023-12 |
| Price to Book Value | 2.46 | Calculated using Price: 706.95 |
| Dividend Yield | 0.35 | Period Ending 2023-03 |
| No. of Shares Subscribed | 0.75 Cr. | 7,508,100 Shares |
| FaceValue | 10 | |
| About 3B Blackbio Dx Ltd. | ||
| Kilpest India is one of India's leading agri-based companies. Kilpest is an ISO certified company and has representation in India in the field of agriculture business comprising crop protection products and public health products, bio products, micro-nutrients and mix fertilizers. The company has one of the most advance Research & Development facility at its Bhopal plant and also has Biological Research Centre. The products are manufactured to high international! BlS specifications with stringent quality control from raw material procurement to finished goods despatch. | ||
| 1 Day |
|
-2.11% |
| 1 Week |
|
-8.07% |
| 1 Month |
|
-4.56% |
| 3 Month |
|
-12.33% |
| 6 Month |
|
-5.49% |
| 1 Year |
|
+63.36% |
| 2 Year |
|
+98.08% |
| 5 Year |
|
+752.26% |
| 10 Year |
|
+9584.25% |
| 9 years | 2015-03 | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | 2023-03 | |
| Return on Equity (%) | 2.33 | 3.26 | 10.47 | 27.55 | 28.99 | 28.15 | 138.73 | 22.59 | 16 | |
| Return on Capital Employed (%) | 6.6 | 6.8 | 12.52 | 23.8 | 28.04 | 32.29 | 179.46 | 29.92 | 21.6 | |
| Return on Assets (%) | 0.96 | 1.37 | 4.55 | 12.22 | 15.71 | 18.94 | 95.54 | 16.7 | 12.77 |
| Particulars | 10 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-09* Rs. Cr. |
| Shh. Funds | 10 | 10 | 11 | 18 | 23 | 32 | 132 | 153 | 171 | 208 | |
| Non Curr. Liab. | 3 | 3 | 4 | 3 | 3 | 2 | 2 | 3 | 4 | 4 | |
| Curr. Liab. | 12 | 10 | 11 | 9 | 10 | 8 | 43 | 17 | 14 | 10 | |
| Minority Int. | 0 | 0 | 0 | 0 | 0 | 2 | 16 | 19 | 25 | 3 | |
| Equity & Liab. | 25 | 24 | 26 | 30 | 36 | 45 | 194 | 192 | 214 | 225 | |
| Non Curr. Assets | 4 | 4 | 4 | 4 | 4 | 6 | 75 | 111 | 100 | 104 | |
| Curr. Assets | 21 | 21 | 22 | 26 | 32 | 39 | 118 | 82 | 114 | 121 | |
| Misc. Exp. not W/O | |||||||||||
| Total Assets | 25 | 24 | 26 | 30 | 36 | 45 | 194 | 192 | 214 | 225 |
| Particulars | 10 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-12 Rs. Cr. TTM |
| Net Sales | 19 | 17 | 16 | 23 | 23 | 29 | 227 | 81 | 62 | 69 | |
| Other Income | 0 | 0 | 0 | 0 | 1 | 2 | 3 | 7 | 7 | 9 | |
| Total Income | 19 | 17 | 16 | 23 | 24 | 30 | 230 | 88 | 69 | 79 | |
| Total Expenditure | -18 | -16 | -14 | -18 | -16 | -20 | -77 | -44 | -33 | -39 | |
| PBIDT | 1 | 2 | 3 | 6 | 8 | 11 | 153 | 44 | 36 | 40 | |
| Interest | -1 | -1 | -1 | -1 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Depreciation | 0 | 0 | 0 | 0 | -1 | -1 | -1 | -1 | -1 | -1 | |
| Taxation | 0 | 0 | 0 | -1 | -2 | -2 | -38 | -11 | -9 | -10 | |
| Exceptional Items | 0 | ||||||||||
| PAT | 0 | 0 | 1 | 3 | 5 | 8 | 114 | 32 | 26 | 29 | |
| Minority Interest | 0 | 0 | -1 | ||||||||
| Share Associate | |||||||||||
| Other Related Items | 0 | ||||||||||
| Consolidated Net Profit | 0 | 0 | 1 | 3 | 5 | 8 | 114 | 32 | 26 | 27 | |
| Adjusted EPS | 1 | 1 | 2 | 5 | 8 | 10 | 152 | 43 | 35 | 34 |
| Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. |
| Cash Fr. Operatn. | 0 | 0 | 1 | 1 | 2 | 4 | 7 | 98 | 37 | 23 | |
| Cash Fr. Inv. | 0 | 0 | 0 | 0 | -1 | -1 | -1 | -70 | -28 | 12 | |
| Cash Fr. Finan. | 0 | 0 | -1 | 0 | 0 | -1 | 1 | -2 | -15 | -5 | |
| Net Change | 0 | 0 | 0 | 1 | 2 | 7 | 26 | -6 | 30 | ||
| Cash & Cash Eqvt | 0 | 0 | 0 | 0 | 2 | 2 | 9 | 35 | 29 | 59 |
|
Thu, 02 May 2024
Board Meeting Intimation for Consideration And Approval Of Audited Financial Results (Standalone And Consolidated) For The Quarter / Year EndedMarch 31 2024 . 3B Blackbio Dx Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2024 inter alia to consider and approve the Audited Financial Results (Standalone and Consolidated) for the quarter / year ended March 31 2024 . |
||||||||||||||||||||||||||||||||||||||||||||||||||
|
Sat, 27 Apr 2024
Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A Format of Initial Disclosure to be made by an entity identified as a Large Corporate.
We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26 2018. No Name of the Company Secretary: Navneet Kaur Designation: Company Secretary EmailId: cs@kilpest.com Name of the Chief Financial Officer: Nikhil Kuber Dubey Designation: CFO and WholeTime Director EmailId: nikhilkuber@gmail.com Date: 27/04/2024 Note: In terms para of 3.2(ii) of the circular beginning F.Y 2022 in the event of shortfall in the mandatory borrowing through debt securities a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore an entity identified as LC shall provide in its initial disclosure for a financial year the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets. |
||||||||||||||||||||||||||||||||||||||||||||||||||
|
Sat, 27 Apr 2024
Format of the Annual Disclosure to be made by an entity identified as a LC - Annexure B2 Format of the Annual Disclosure to be made by an entity identified as a Large Corporate.
Date: 27/04/2024 |
||||||||||||||||||||||||||||||||||||||||||||||||||
| Tue, 07 May 2024 |
High Delivery Percentage
|
Closing Below Previous Low
|
Making Lower Lows for 3 days
|
Closing Below Previous Low for 2 Days
|
Making Lower Lows for 2 Days
|
